The primary method of analysis, the IVW method, revealed no statistically significant association between an increased EGFR and European men’s prostate cancer risk (odds ratio (OR) = 1.0; 95% confidence interval (CI) = 0.9-1.0;P = 0.6). The gene discussed is EGFR; the disease is prostate carcinoma.